New mRNA vaccine shows promise against childhood cancer
新型mRNA疫苗在兒童癌症治療上展現潛力
更新於: 2026年6月19日 上午08:00
Medical researchers are making exciting strides in treating childhood cancer by adapting mRNA technology once used for COVID-19 vaccines.
醫學研究人員正在利用曾經用於COVID-19疫苗的mRNA技術，在治療兒童癌症方面取得令人振奮的進展。
While vaccines are usually for prevention, this new approach uses them as a therapeutic tool to fight existing tumors.
雖然疫苗通常用於預防，但這種新方法將其作為一種治療工具，用來對抗現有的腫瘤。
A recent breakthrough at the RCSI University of Medicine and Health Sciences focused on neuroblastoma, a particularly deadly childhood cancer.
最近，愛爾蘭皇家外科醫學院(RCSI)在神經母細胞瘤這一種特別致命的兒童癌症上取得了突破。
By using peptide nanoparticles, scientists delivered mRNA instructions to train the immune system to hunt for a protein called GPC2 found on cancer cells.
科學家透過肽奈米顆粒，將mRNA指令傳遞給免疫系統，訓練其去獵殺癌細胞上發現的一種稱為GPC2的蛋白質。
Other initiatives are exploring personalized mRNA vaccines for childhood brain cancers.
其他計畫也在探索針對兒童腦癌的個人化mRNA疫苗。
By analyzing a child's specific tumor genetics, doctors can create custom treatments that re-educate the immune system to recognize and attack cancer cells it previously ignored.
透過分析兒童特定腫瘤的遺傳基因，醫生可以創造客製化的治療方案，重新訓練免疫系統去辨識並攻擊先前被其忽略的癌細胞。
While the field is still in early clinical stages, this innovative approach aims to prevent cancer relapse and significantly improve the quality of life for pediatric patients everywhere.
儘管該領域仍處於臨床早期階段，但這種創新方法旨在防止癌症復發，並顯著改善全球兒科患者的生活品質。
